Gene: TP53I13
Official Full Name: tumor protein p53 inducible protein 13provided by HGNC
Gene Summary: Involved in several processes, including negative regulation of cell cycle; response to UV; and response to xenobiotic stimulus. Located in cytoplasm. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO23801 | TP53I13 Knockout cell line (HeLa) | Human | TP53I13 | 1:3~1:6 | Negative | Online Inquiry |
KO23802 | TP53I13 Knockout cell line (HCT 116) | Human | TP53I13 | 1:2~1:4 | Negative | Online Inquiry |
KO23803 | TP53I13 Knockout cell line (HEK293) | Human | TP53I13 | 1:3~1:6 | Negative | Online Inquiry |
KO23804 | TP53I13 Knockout cell line (A549) | Human | TP53I13 | 1:3~1:4 | Negative | Online Inquiry |
TP53I13 Gene Knockout Cell Lines are specialized cellular models designed to facilitate the comprehensive study of the TP53I13 gene, a vital player in various cellular processes including apoptosis and genomic stability. The knockout of this gene allows researchers to dissect its functions and the mechanisms underlying its influence on cancer biology, cellular stress responses, and tissue regeneration. These cell lines have been engineered using advanced CRISPR-Cas9 technology, ensuring precise deletion of the TP53I13 gene, which is crucial for generating reproducible and consistent experimental results that reflect the gene’s native biological roles.
The primary function of TP53I13 Gene Knockout Cell Lines lies in their ability to mimic specific pathological conditions, allowing for detailed investigation into tumorigenesis, therapeutic resistance, and potential drug targets. By understanding the role of TP53I13 in these processes, researchers can unlock new strategies for cancer treatment and diagnostics. These cell lines are invaluable in both academic and clinical research settings, fostering breakthroughs in molecular oncology and personalized medicine.
What sets TP53I13 Gene Knockout Cell Lines apart from alternative models is their effortless integration into existing experimental workflows, combined with their adaptability to various assays, including drug response and gene expression analyses. Their robust validation and characterization ensure that researchers can rely on consistent performance, which is critical for downstream applications.
For researchers and clinicians seeking to delve deeper into the cellular mechanisms influenced by the TP53I13 gene, these knockout cell lines present an unparalleled opportunity. They not only accelerate the pace of discovery by providing clear insights into gene function but can also enhance the predictive power of preclinical studies.
Our company is committed to advancing biotechnological innovations, offering an array of high-quality biological reagents and cellular models that empower researchers to make significant strides in their scientific endeavors. With our expertise in genetic engineering and deep understanding of molecular biology, we provide essential tools that drive the future of research and therapeutic development.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.